Drug reference

malaria vaccine

recombinant protein-based vaccine with AS01 adjuvant · vaccine

recombinant protein-based vaccine with AS01 adjuvantvaccine

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

The RTS,S malaria vaccine is a recombinant protein-based vaccine combined with AS01 adjuvant, designed to induce immunity against Plasmodium falciparum, a common cause of malaria in sub-Saharan Africa.

Indications

prevention of Plasmodium falciparum malaria

Related guidelines

Malaria treatment

ICMR · Infectious Disease · 2021

Infective endocarditis prevention

ADA_DENTAL · Dentistry · 2015

Stroke and TIA — secondary prevention

AHA · Neurology · 2021

Tobacco-related cancer prevention

ICMR · Oncology · 2021

Cardiovascular disease prevention

ESC · Cardiology · 2021

Ask House about malaria vaccine

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team